GZB: Stimulator, Spinal-Cord, Implanted (Pain Relief)
What it covers
An implanted spinal cord stimulator for pain relief is a device that is used to stimulate electrically a patient's spinal cord to relieve severe intractable pain. The stimulator consists of an implanted receiver with electrodes that are placed on the patient's spinal cord and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.
The identification in 21 CFR 882.5880, implanted spinal cord stimulator for pain relief. FDA gives GZB no definition of its own, so the regulation’s describes it.
FDA flags GZB devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K233801 | Nalu Neurostimulation System for Spinal Cord Stimulation; Nalu Neurostimulation System for Peripheral Nerve Stimulation | Boston Scientific Neuromodulation | Aug 23, 2024 | Traditional |
| K221376 | Nalu Neurostimulation System | Boston Scientific Neuromodulation | Jun 10, 2022 | Special |
| K203547 | Nalu Neurostimulation System | Boston Scientific Neuromodulation | Mar 25, 2021 | Traditional |
| K202274 | Nalu Neurostimulation Kit (lnte:gmted 40 em: Single 8/Dual 8), Nalu Neurostimulation Kit (Ported, 2 em: Single 8/Dual8), Dual 8 Ported Nalu Implantable Pulse Generator with 40 ern Kil, 40 cm/ 60 cm/60 em TrialJExtension Lead Kits, Patient Kits and miscellaneous replacement kits | Boston Scientific Neuromodulation | Nov 9, 2020 | Traditional |
| K201618 | Nalu Neurostimulation SCS system | Boston Scientific Neuromodulation | Jul 15, 2020 | Special |
| K191466 | SandShark Injectable Anchor (SIA) System | Stimwave Technologies, Inc. | Nov 7, 2019 | Traditional |
| K190960 | Nalu Lead Blank (50cm) | Boston Scientific Neuromodulation | Jul 11, 2019 | Traditional |
| K182720 | Freedom Spinal Cord Stimulator (SCS) System | Stimwave Technologies Incorporated | Mar 29, 2019 | Traditional |
| K183047 | Nalu Neurostimulation System | Boston Scientific Neuromodulation | Mar 22, 2019 | Traditional |
| K180981 | Stimulator Kit, Trial Kit, Spare Lead Kit, Wearable Assembly Kit | Stimwave Technologies Incorporated | Sep 19, 2018 | Traditional |
Clearances by year
26 GZB 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2024 | 1 | 268 |
| 2022 | 1 | 29 |
| 2021 | 1 | 111 |
| 2020 | 2 | 60 |
| 2019 | 4 | 149 |
| 2018 | 1 | 159 |
| 2017 | 2 | 84 |
| 2016 | 2 | 157 |
| 2015 | 2 | 104 |
| 2014 | 2 | 112 |
| 2013 | 2 | 98 |
| 2012 | 2 | 99 |
| 2011 | 4 | 67 |
Who submits
7 applicants cleared a GZB device since 2011. 100% of the clearances went to applicants in United States. By type: Traditional 85% and Special 15%.
| Applicant | Clearances since 2011 |
|---|---|
| Stimwave Technologies Incorporated | 8 |
| Boston Scientific Neuromodulation | 7 |
| Anulex Technologies, Inc. | 4 |
| St Jude Medical | 3 |
| St. Jude Medical Neuromodulation | 2 |
| Anchor Innovation Medical (A.I.M.) | 1 |
| Stimwave Technologies, Inc. | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 882.5880.
Standards
21 CFR 882.5880 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GZB clearances declared.
Ask about GZB
Questions about GZB
What is FDA product code GZB?
Product code GZB, “Stimulator, Spinal-Cord, Implanted (Pain Relief)” in FDA's classification database, is a Class II device type under 21 CFR 882.5880 (implanted spinal cord stimulator for pain relief), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 139 clearances under GZB, 26 of them since 2011.
How many 510(k) clearances are there under GZB?
FDA’s 510(k) database listed 139 clearances under GZB as of Oct 29, 2026, 26 of them decided since 2011; the most recent decision was Aug 23, 2024. The Predicate Finder searches the live database.
Which companies have the most GZB clearances?
Since 2011: Stimwave Technologies Incorporated (8), Boston Scientific Neuromodulation (7), Anulex Technologies, Inc. (4), St Jude Medical (3) and St. Jude Medical Neuromodulation (2). 7 applicants have cleared a GZB device in that time.